Full Info:

Resource Type:

Webinar

Citation:

Many preclinical product candidates never reach clinical development as a result of clinical trial hurdles, often referred to as the “valley of death.”

This webinar in the “Let’s Talk MPTs” discussion series focused on successful strategies and lessons learned for progressing an MPT product candidate from preclinical through to clinical development. It provided a valuable opportunity to hear from MPT product developers and experts on their experiences working to overcome this challenge and ensure that promising products can progress through clinical trials to reach the hands of end-users.

Featured discussants included:

• Meredith Clark, CONRAD
• Ruth Merkatz, Population Council
• Nyaradzo Mgodi, Harare Health and Research Consortium
• Jim Turpin, TurHow Consulting Group, LLC
• Ariane van der Straten, University of California San Francisco (UCSF) & ASTRA Consulting

This webinar series is sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). For this webinar topic we were pleased to collaborate with partners from the Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence (MATRIX) Project.

Authors: The IMPT, Meredith Clark, Ruth Merkatz, Nyaradzo Mgodi, Jim Turpin, Ariane van der Straten, Bethany Young Holt

Health Risks(s):

• HIV
• STI / STD
• Unintended Pregnancy

Product type(s):

• MPTs

Topic(s):

• Funding
• MPTs
• Development
• Trials
• Regulatory
• Social

Region(s)

• Global

Additional Keywords:

Product development, Preclinical, Clinical Development, Valley of Death